Radboud Annals of Medical Students

RAMS

  • Home
  • News
    • Newsletter archive
  • About
    • RAMS
    • The Board
      • The General Board
        • The General Board (2021-2022)
        • Previous General Boards
      • The Editorial Board
        • The Editorial Board (2021-2022)
        • Previous Editorial Boards
    • The Supervisory Board
    • Reviewers and Editors
    • RAMS Committees
      • Symposium Committee
      • Masterclass Committee
  • Editions
    • 2021-2022
      • Twentieth Edition – September 2021
      • Twentyfirst Edition – December 2021
      • Twenty second Edition – March 2022
    • 2020-2021
      • Sixteenth edition – September 2020
      • Seventeenth edition – December 2020
      • Eighteenth edition – March 2021
      • Nineteenth Edition – June 2021
    • 2019-2020
      • Fourteenth edition – December 2019
      • Fifteenth edition – April 2020
      • Sixteenth edition – September 2020
    • 2018-2019
      • Eleventh Edition – September 2018
      • Twelfth Edition – January 2019
      • Thirteenth edition – May 2019
    • 2017 – 2018
      • Ninth Edition – November 2017
      • Tenth Edition – February 2018
    • 2016-2017
      • Sixth Edition – November 2016
      • Seventh Edition – March 2017
      • Eighth Edition – July 2017
    • 2015-2016
      • Third Edition – November 2015
      • Fourth Edition – March 2016
      • Fifth Edition – June 2016
    • 2014-2015
      • Pilot Edition – June 2014
      • First Edition – January 2015
      • Second Edition – June 2015
  • For Authors
    • Submit your Article
    • Research internship
  • For Supervisors
  • For Reviewers
  • Contact
  • Privacy policy
Je bent hier: Home / News / The Placebo Effect: Just a Trick?

The Placebo Effect: Just a Trick?

31 maart 2019 by Rams

Joyce Krekels

Some time ago, I went to the RAMS symposium ‘Placebo effect: The Mind as Medicine’, where professor Andrea Evers and PhD student Judith Tekampe from Leiden University spoke about positive (placebo) and negative (nocebo) treatment effects that occur as a result of a patient’s expectations and beliefs about the effect of a certain treatment or its side effects (1). This urged me to dig a little bit deeper into the placebo effect and how it can be applied in the clinic. Remarkably, placebo and nocebo effects are seen in almost every condition and physiological response system, such as in immune and endocrine functioning (1). But how can we use these effects as a treatment?

Let’s start with a few factors that can influence the impact of the placebo effect. Among others, the doctor-patient relationship and the phrasing of the doctor matters in this case. Research conducted by Howe et al. showed an enhancement of the placebo effect when the doctor appeared warm and competent compared to when a doctor appeared cold and incompetent(2). Also, the type (injected or orally), size and colour (blue, red or green) of the medication that is given, affects the impact of the placebo effect (3, 4). In addition, there might even be a role for genetics where it, more specifically, can influence the response to neurotransmitters such as in the dopamine, endocannabinoid and opioid pathways (5, 6).

Currently, evidence in cardiovascular medicine suggests that a placebo might reduce symptoms and possibly autonomic responses such as hypertension, congestive heart failure, paroxysmal atrial fibrillation and vasovagal syncope (7). Especially for relieving anxiety (and the response of the autonomic nervous system to anxiety and stress) and pain, placebo effects can possibly be very substantial (7). In an already older study from Levine et al., it is already shown that if patients are told that a painkiller is injected after extraction of the third molar, with what is actually a saline solution, this works as potent as a dose of 6-8 mg of morphine (8). This also holds for other painkillers, such as tramadol and buprenorphine (7). In the dermatological field, research towards chronic itch in patients with psoriasis, atopic dermatitis and chronic idiopathic urticaria, showed that itching can be considerably reduced by placebo effects (9). Also, research in this field showed that learned (conditioned) immune functioning is possible, whereby conditioning to antihistamines or cyclosporine led to relieve of subjective rhinitis symptoms, allergic skin reactions and induces changes in effector immune functions when researchers provoked allergic reactions in participants who had a house-dust mite allergy (1, 10).

As more researchers have been debating the mechanisms of placebo and nocebo effects and how we can use this optimally in clinical practice for years, recent research focuses more on the use the of these effects on therapy outcomes in clinical practice. Still, the most challenging aspects of this research are that some studies are insufficiently powered to account for the impact of these effects. However, there is increasing attention for research on the placebo and nocebo effect, for example at the international SIPS conference that will be held in Leiden for the second time  (www.sipsconference.com), including research on the complex interplay of neurobiological and psychological factors, or the ethical considerations that need to be dealt with. Despite this, research on placebo effects may change the medication dose description by pharmacological conditioning, the way we feel about both pharmacological and non-pharmacological treatment, and train doctors to exploit the placebo effect by, for example, improving the doctor-patient relationship and being aware of the phrasing they use.

 

[1] Evers AW. Using the placebo effect: how expectations and learned immune function can optimize dermatological treatments. Exp Dermatol. 2017;26(1):18-21.
[2] Howe LC, Goyer JP, Crum AJ. Harnessing the placebo effect: Exploring the influence of physician characteristics on placebo response. Health Psychol. 2017;36(11):1074-82.
[3] Bhugra D, Ventriglio A, Till A, Malhi G. Colour, culture and placebo response. Int J Soc Psychiatry. 2015;61(6):615-7.
[4] Peerdeman KJ, Tekampe J, van Laarhoven AIM, van Middendorp H, Rippe RCA, Peters ML, et al. Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes. Eur J Pain. 2018;22(4):774-83.
[5] Sheldon R, Opie-Moran M. The Placebo Effect in Cardiology: Understanding and Using It. Can J Cardiol. 2017;33(12):1535-42.
[6] Hall KT, Loscalzo J, Kaptchuk TJ. Genetics and the placebo effect: the placebome. Trends Mol Med. 2015;21(5):285-94.
[7] Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014;84(3):623-37.
[8] Levine JD, Gordon NC, Smith R, Fields HL. Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain. 1981;10(3):379-89.
[9] van Laarhoven AIM, van der Sman-Mauriks IM, Donders ART, Pronk MC, van de Kerkhof PCM, Evers AWM. Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions. J Invest Dermatol. 2015;135(5):1234-43.
[10] Goebel MU, Meykadeh N, Kou W, Schedlowski M, Hengge UR. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom. 2008;77(4):227-34.

Categorie: News, Uncategorized

RAMS Newsletter

RAMS complies to the GDPR. By submitting your e-mail address to us you agree with our Privacy Policy.

Social Media


Sponsors & Partners

  • Brian Gardner
  • Lauren Mancke
  • Nathan Rice
  • Nick Croft
  • Rafal Tomal
  • Ron Rennick
© Copyright 2014 RADBOUD ANNALS OF MEDICAL STUDENTS · All Rights Reserved · Powered by PLatform11
Beheer cookie toestemming

Om de beste ervaringen te bieden, gebruiken wij technologieën zoals cookies om informatie over je apparaat op te slaan en/of te raadplegen. Door in te stemmen met deze technologieën kunnen wij gegevens zoals surfgedrag of unieke ID's op deze site verwerken. Als je geen toestemming geeft of uw toestemming intrekt, kan dit een nadelige invloed hebben op bepaalde functies en mogelijkheden.

Functioneel Altijd actief
De technische opslag of toegang is strikt noodzakelijk voor het legitieme doel het gebruik mogelijk te maken van een specifieke dienst waarom de abonnee of gebruiker uitdrukkelijk heeft gevraagd, of met als enig doel de uitvoering van de transmissie van een communicatie over een elektronisch communicatienetwerk.
Voorkeuren
De technische opslag of toegang is noodzakelijk voor het legitieme doel voorkeuren op te slaan die niet door de abonnee of gebruiker zijn aangevraagd.
Statistieken
De technische opslag of toegang die uitsluitend voor statistische doeleinden wordt gebruikt. De technische opslag of toegang die uitsluitend wordt gebruikt voor anonieme statistische doeleinden. Zonder dagvaarding, vrijwillige naleving door uw Internet Service Provider, of aanvullende gegevens van een derde partij, kan informatie die alleen voor dit doel wordt opgeslagen of opgehaald gewoonlijk niet worden gebruikt om je te identificeren.
Marketing
De technische opslag of toegang is nodig om gebruikersprofielen op te stellen voor het verzenden van reclame, of om de gebruiker op een website of over verschillende websites te volgen voor soortgelijke marketingdoeleinden.
Beheer opties Beheer diensten Beheer leveranciers Lees meer over deze doeleinden
Bekijk voorkeuren
{title} {title} {title}